Posted On: 02/09/2015 10:21:15 AM
Post# of 6
A Silent Killer, A White Knight, And A Compelling Long Opportunity: Miraculins Inc. 2 comments
Feb 5, 2015 6:24 AM | about stocks: MCUIF
Summary
Diabetes is a 'silent killer', you can have diabetes for years without any symptoms and the only way to know for sure is to be tested
Huge market opportunity in the early detection of pre-diabetes, type 2 diabetes and coronary artery disease
Scout DS® is cleared for sale as a screen for pre-diabetes and type 2 diabetes in Canada, Mexico, and has been CE-Marked for the EU , with pre-submission documentation for de novo classification in the U.S. in process
Between $40-$50 million has already invested into the Scout DS® technology
Potential to scale quickly once marketing issues have been worked through, currently conducting pilot programs
The world is in the grip of a diabetes pandemic.
Diabetes is a serious health condition of elevated blood sugars where the body doesn't produce enough insulin to meet its needs, or the body does not respond properly to the insulin being made. Insulin is critical as it moves glucose into the body's cells from the blood. It is a disease that can have devastating complications and consequences
In human and financial terms, the burden is immense and it's now hitting the poor especially hard. Traditionally thought of as a disease of the rich, experts say the alarming rise may be fuelled as much by food scarcity and insecurity as it is by excess. New lifestyles, rapid urbanisation and cheap calories in the form of processed foods are putting more and more people at risk of developing Type-2 diabetes.
http://seekingalpha.com/instablog/27523743-po...culins-inc
Feb 5, 2015 6:24 AM | about stocks: MCUIF
Summary
Diabetes is a 'silent killer', you can have diabetes for years without any symptoms and the only way to know for sure is to be tested
Huge market opportunity in the early detection of pre-diabetes, type 2 diabetes and coronary artery disease
Scout DS® is cleared for sale as a screen for pre-diabetes and type 2 diabetes in Canada, Mexico, and has been CE-Marked for the EU , with pre-submission documentation for de novo classification in the U.S. in process
Between $40-$50 million has already invested into the Scout DS® technology
Potential to scale quickly once marketing issues have been worked through, currently conducting pilot programs
The world is in the grip of a diabetes pandemic.
Diabetes is a serious health condition of elevated blood sugars where the body doesn't produce enough insulin to meet its needs, or the body does not respond properly to the insulin being made. Insulin is critical as it moves glucose into the body's cells from the blood. It is a disease that can have devastating complications and consequences
In human and financial terms, the burden is immense and it's now hitting the poor especially hard. Traditionally thought of as a disease of the rich, experts say the alarming rise may be fuelled as much by food scarcity and insecurity as it is by excess. New lifestyles, rapid urbanisation and cheap calories in the form of processed foods are putting more and more people at risk of developing Type-2 diabetes.
http://seekingalpha.com/instablog/27523743-po...culins-inc
(0)
(0)
